Liquidia Corp. (LQDA)
70.27
+1.65
(+2.40%)
USD |
NASDAQ |
Aug 24, 16:00
70.28
0.00 (0.00%)
After-Hours: 20:00
Liquidia Total Return Level : 70.27 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 70.27 |
| August 21, 2026 | 68.62 |
| August 20, 2026 | 71.05 |
| August 19, 2026 | 75.33 |
| August 18, 2026 | 74.33 |
| August 17, 2026 | 77.70 |
| August 14, 2026 | 74.44 |
| August 13, 2026 | 72.10 |
| August 12, 2026 | 78.79 |
| August 11, 2026 | 88.05 |
| August 10, 2026 | 91.03 |
| August 07, 2026 | 90.22 |
| August 06, 2026 | 89.42 |
| August 05, 2026 | 89.12 |
| August 04, 2026 | 88.38 |
| August 03, 2026 | 83.85 |
| July 31, 2026 | 84.11 |
| July 30, 2026 | 86.80 |
| July 29, 2026 | 86.82 |
| July 28, 2026 | 86.82 |
| July 27, 2026 | 84.42 |
| July 24, 2026 | 86.22 |
| July 23, 2026 | 89.03 |
| July 22, 2026 | 87.04 |
| July 21, 2026 | 80.89 |
| Date | Value |
|---|---|
| July 20, 2026 | 77.08 |
| July 17, 2026 | 79.94 |
| July 16, 2026 | 75.27 |
| July 15, 2026 | 77.75 |
| July 14, 2026 | 76.49 |
| July 13, 2026 | 71.21 |
| July 10, 2026 | 77.93 |
| July 09, 2026 | 81.45 |
| July 08, 2026 | 79.47 |
| July 07, 2026 | 81.23 |
| July 06, 2026 | 79.21 |
| July 02, 2026 | 78.93 |
| July 01, 2026 | 79.32 |
| June 30, 2026 | 79.73 |
| June 29, 2026 | 75.12 |
| June 26, 2026 | 78.17 |
| June 25, 2026 | 76.92 |
| June 24, 2026 | 75.54 |
| June 23, 2026 | 74.04 |
| June 22, 2026 | 75.49 |
| June 18, 2026 | 71.07 |
| June 17, 2026 | 68.65 |
| June 16, 2026 | 68.01 |
| June 15, 2026 | 71.80 |
| June 12, 2026 | 71.23 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Indivior Pharmaceuticals, Inc. | 37.63 |
| Harmony Biosciences Holdings, Inc. | 38.50 |
| Johnson & Johnson | 648.35 |
| Amneal Pharmaceuticals, Inc. | 17.78 |
| Corcept Therapeutics, Inc. | 123.24 |